To Order or Get Information
Directions for Using Eleotin®
Diabetic Cook Books
Research for Type I Diabetics |
 |
To place an order for ELEOTIN® contact one of the following:
 |
E-mail: |
 |
Phone:
|
 |
Fax:
604-247-2101 |
 |
|
| CLICK TO ORDER ON-LINE |
REQUEST MORE INFORMATION |
| 1. PRESCRIBED MEDICATION
- DO NOT discontinue or modify the level of consumption of any prescribed
medication. Your doctor should make all prescription changes.
2. ALCOHOL - Please abstain or minimize
your alcohol intake. Alcohol consumption considerably diminishes the effectiveness
of ELEOTIN®.
3. RECOMMENDED CONSUMPTION - ELEOTIN® should be consumed 3-5 times a day. The following schedule is recommended: Orange Box -
One -Two drinks a day (30 minutes before a large meal).
4. ELEOTIN ®POUCHES - Each 8 grams pouch can make either two medium-strong drinks or four weaker drinks. We recommended that you start slowly and work your way up to the medium-strong drinks. If any discomfort is detected, please reduce the drink strength for a while. If discomfort persists for an extended period, discontinue use. 5. PREPARATION OPTIONS: i) The most effective preparation is to brew
ELEOTIN® like other oriental herbs. This involves slowly brewing
the powder over low heat to allow for the active ingredients to seep out
into the water. The amount of water depends on your preference. The water
is to be reduced to a volume of 180ml after brewing. You may either use
less water to enjoy a strong taste, or use more water to have several weak
drinks throughout the day. It does not matter which method you prefer.
*However, please keep in mind that more quantity does not necessarily mean
better results. The recommended dosage of ELEOTIN® is ½
to ¼ of one pouch.
6. SEDIMENT CONSUMPTION -
After finishing an ELEOTIN® drink you may notice residual sediment
at the bottom of your container/glass. This sediment is extremely beneficial
and should be consumed or made into another drink.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ELEOTIN® was initially
developed at the University of Calgary, Canada for Type II diabetics. Animal
and human trials conducted at the University of Calgary have produced consistent
results. Human tests using ELEOTIN® for three to six months
have shown the following
As of June 2001, ELEOTIN® has been sold to over 20,000 Type II diabetics since March 1998. We have extremely encouraging results from these initial users and are confident in recommending ELEOTIN® to all Type II diabetics. New Preliminary Results Recently, EBMR has begun testing a modified version
of ELEOTIN® on Type I diabetics. To date, we have only
tested handful of Type I diabetics with ELEOTIN® over a three-month
period. So far the tests have shown some surprisingly positive results.
All have had BGL (Blood Glucose Levels) reductions and one person has,
with the approval of his doctor, reduced his daily insulin intake. All
have indicated that they feel healthier. Please, refer to the
science section of this web site for detailed information on the test.
We are encouraged but, we would like to caution you not to be too optimistic.
|
